Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-trimoxazole Prophylaxis in Rapid ART Initiation with Low CD4 Counts
TCTR20260116002Phase 4Recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trimethoprim + sulfamethoxazole in human immunodeficiency virus infection (HIV), opportunistic infection, sponsored by Phramongkutklao Hospital. Started Dec 2025; status: recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
human immunodeficiency virus infection (HIV)opportunistic infection
Beyond the preview
Go deeper on TCTR20260116002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260116002.